Discontinued — last reported Q4 '23

Business Segments · Operating Income (Loss)

Health — Operating Income (Loss)

Leidos Holdings Health — Operating Income (Loss) decreased by 3.3% to $147.00M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 70.9%, from $86.00M to $147.00M. Over 2 years (FY 2021 to FY 2023), Health — Operating Income (Loss) shows an upward trend with a 9.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ4 2023Feb 13, 2024
Rolls up toOperating Income

How to read this metric

Higher income indicates improved operational efficiency, better pricing power, or effective cost management within the segment.

Detailed definition

Measures the profitability of the Health segment by subtracting operating expenses from segment revenues. It reflects th...

Peer comparison

Standard segment reporting metric across all publicly traded companies, comparable to 'Segment Operating Profit'.

Metric ID: ldos_segment_health_operating_income_loss

Historical Data

12 periods
 Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23
Value$102.00M$107.00M$130.00M$103.00M$118.00M$126.00M$91.00M$86.00M$107.00M$122.00M$152.00M$147.00M
QoQ Change+4.9%+21.5%-20.8%+14.6%+6.8%-27.8%-5.5%+24.4%+14.0%+24.6%-3.3%
YoY Change+15.7%+17.8%-30.0%-16.5%-9.3%-3.2%+67.0%+70.9%
Range$86.00M$152.00M
CAGR+14.2%
Avg YoY Growth+14.1%
Median YoY Growth+6.3%

Frequently Asked Questions

What is Leidos Holdings's health — operating income (loss)?
Leidos Holdings (LDOS) reported health — operating income (loss) of $147.00M in Q4 2023.
How has Leidos Holdings's health — operating income (loss) changed year-over-year?
Leidos Holdings's health — operating income (loss) increased by 70.9% year-over-year, from $86.00M to $147.00M.
What is the long-term trend for Leidos Holdings's health — operating income (loss)?
Over 2 years (2021 to 2023), Leidos Holdings's health — operating income (loss) has grown at a 9.3% compound annual growth rate (CAGR), from $442.00M to $528.00M.
What does health — operating income (loss) mean?
The profit or loss generated by the Health business segment from its core operations.